Biotech labs are using AI inspired by DALL-E to invent new drugs | MIT Technology Review

Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.

Biotech labs are using AI inspired by DALL-E to invent new drugs | MIT Technology Review Skip to Content The explosion in text-to-image AI models like OpenAI’s DALL-E 2 —programs trained to generate pictures of almost anything you ask for—has sent ripples through the creative industries, from fashion to filmmaking, by providing weird and wonderful images on demand. The same technology behind these programs is also making a splash in biotech labs, which have started using this type of generative AI, known as a diffusion model, to conjure up designs for new types of protein never seen in nature.

related reading

• AlphaProteo generates novel proteins for biology and health researchdeepmind.google
• Evo 2 Can Design Entire Genomesasimov.press
• How AI Revolutionized Protein Science, but Didn’t End It | Quanta Magazinequantamagazine.org
• Reimagining Drug Discovery Process with AI - Isomorphic Labsisomorphiclabs.com
• ⭐️ Diffusion Modelsandrewkchan.dev
• Engineering Plastic-Degrading Enzymes and PCSK9 Binders with Protein AI Toolsblog.latch.bio
• De novo design of protein structure and function with RFdiffusion | Naturenature.com
• Google DeepMind and Isomorphic Labs introduce AlphaFold 3 AI modelblog.google
• New AI Research Could Drive Progress in Medicine and Clean Energyabout.fb.com
• OCTO - Noetiknoetik.ai
• AI is dreaming up drugs that no one has ever seen. Now we've got to see if they work. | MIT Technology Reviewtechnologyreview.com
• One-shot design of functional protein binders with BindCraftnature.com